1. Home
  2. EARN vs CATX Comparison

EARN vs CATX Comparison

Compare EARN & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$5.32

Market Cap

189.7M

Sector

Real Estate

ML Signal

HOLD

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

HOLD

Current Price

$2.75

Market Cap

211.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
CATX
Founded
2012
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.7M
211.1M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
EARN
CATX
Price
$5.32
$2.75
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$5.88
$11.56
AVG Volume (30 Days)
323.8K
1.6M
Earning Date
02-20-2026
11-10-2025
Dividend Yield
18.18%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,893,000.00
$1,075,000.00
Revenue This Year
$8.43
N/A
Revenue Next Year
$17.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
43.30
N/A
52 Week Low
$4.33
$1.60
52 Week High
$6.86
$5.39

Technical Indicators

Market Signals
Indicator
EARN
CATX
Relative Strength Index (RSI) 52.63 56.59
Support Level $5.10 $2.45
Resistance Level $5.20 $2.90
Average True Range (ATR) 0.10 0.21
MACD -0.00 0.06
Stochastic Oscillator 60.18 81.18

Price Performance

Historical Comparison
EARN
CATX

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: